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ABSTRACT
Pancreatic stellate cells (PSCs) play a critical role in the progression of pancreatic 
ductal adenocarcinoma (PDAC). Once activated, PSCs support proliferation and 
metastasis of carcinoma cells. PSCs even co-metastasise with carcinoma cells. This 
requires the ability of PSCs to migrate. In recent years, it has been established that 
almost all "hallmarks of cancer" such as proliferation or migration/invasion also 
rely on the expression and function of ion channels. So far, there is only very limited 
information about the function of ion channels in PSCs. Yet, there is growing evidence 
that ion channels in stromal cells also contribute to tumor progression. Here we 
investigated the function of KCa3.1 channels in PSCs. KCa3.1 channels are also found 
in many tumor cells of different origin. We revealed the functional expression of 
KCa3.1 channels by means of Western blot, immunofluorescence and patch clamp 
analysis. The impact of KCa3.1 channel activity on PSC function was determined with 
live-cell imaging and by measuring the intracellular Ca2+ concentration ([Ca2+]i). 
KCa3.1 channel blockade or knockout prevents the stimulation of PSC migration and 
chemotaxis by reducing the [Ca2+]i and calpain activity. KCa3.1 channels functionally 
cooperate with TRPC3 channels that are upregulated in PDAC stroma. Knockdown of 
TRPC3 channels largely abolishes the impact of KCa3.1 channels on PSC migration. 
In summary, our results clearly show that ion channels are crucial players in PSC 
physiology and pathophysiology.
INTRODUCTION
Pancreatic stellate cells (PSCs) constitute a small 
fraction of cells in the periacinar space that are normally 
quiescent. Their function in a healthy pancreas has begun 
to be unravelled only recently. Roles in matrix turnover, 
regulation of exocrine secretion, immune functions, as 
well as progenitor functions have been shown [1–3]. It is 
well established that activated PSCs as well as infiltrating 
myeloid cells and lymphocytes are of great importance 
in pancreatic pathologies such as chronic (alcoholic) 
pancreatitis or pancreatic ductal adenocarcinoma (PDAC). 
PSCs are the predominant mesenchymal cells within the 
PDAC stroma [4]. They are activated by growth factors 
and cytokines (e.g. PDGF and TGF-β, IL8 and TNF-a) 
produced by tumor cells or by themselves (autocrine 
stimulation [5, 6]). Activated PSCs have an enhanced 
migratory activity, and in turn, secrete growth factors and 
cytokines. In PDAC this is the basis for mutual paracrine 
stimulation of tumor and stroma cells that leads, in a 
positive feedback cycle, to excessive matrix production 
(desmoplasia) and creates a hypoxic microenvironment 
conducive to invasive tumor growth and metastasis [7, 8]. 
Thus, the characteristic tumor stroma of PDAC and the 
mutual interaction of all its components play important 
roles in many aspects of tumor progression and in 
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preventing efficient therapy. Accordingly, activated PSCs 
are in part responsible for the high mortality of PDAC 
patients whose 5-year survival rate is less than 5% [9]. 
However, there is some controversy with respect to this 
issue, since myofibroblasts have recently been shown to 
protect the host from the tumor [10, 11].
So far, there is limited knowledge on the function 
and expression of ion channels in PDAC [12–17]. Based 
on the critical role of ion channels in other tumors [18], 
it is reasonable to predict that they are important drivers 
of PDAC progression as well. We assume that this also 
applies for ion channels in PSCs. However, so far the role 
of ion channels in PSC physiology and pathophysiology 
is rather unexplored. There are only very few studies 
addressing this topic [19–22] some of which were 
performed on the closely related hepatic stellate cells [23, 
24]. Yet, in analogy to other cell types of the tumor stroma 
it is very likely that altered ion channel expression and 
function in stimulated PSCs contribute to processes that 
are critical for PDAC progression such as cell migration 
and invasion, growth factor signaling, or proliferation and 
apoptosis [25]. In the present study we investigated the 
role of ion channels in PSC migration. Migration of PSCs 
has to be seen against the background that PSCs are also 
found in distant PDAC metastases [2] so that migration of 
PSCs is one of the prerequisites of co-metastases [25]. One 
of the best studied ion channels involved in cell migration 
is a Ca2+ sensitive K+ channel of intermediate conductance, 
KCa3.1, which is expressed in almost all migrating cells 
[26–28]. Here we show that KCa3.1 channels are also 
expressed in PSCs and contribute in cooperation with 
TRPC3 channels to their migratory activity.
RESULTS
Functional KCa3.1 channel expression in RLT-
PSC cells
Western blot analysis revealed that KCa3.1 channels 
are expressed in RLT-PSCs. Incubation of RLT-PSCs in 
conditioned PDAC cell medium does not increase KCa3.1 
expression, which is consistent with the analysis of 
published micorarrays (see below). Immunofluorescence 
staining yielded the typical punctate staining of the 
channel protein (Figure 1A). A similar staining pattern 
is also observed in primary cultures of murine PSCs 
(Figure 1B). KCa3.1 staining is absent in PSCs isolated 
from KCa3.1
−/− mice (Figure 1C). The final proof for 
the expression of functional KCa3.1 channel proteins in 
the plasma membrane was obtained from patch clamp 
experiments. Using a KCl containing pipette solution 
we recorded an outwardly rectifying whole-cell current 
with the typical pharmacological properties of KCa3.1 
channels (n = 8; see Figure 1D [29]). Mean current density 
rises from 4.8 ± 1.0 pA/pF under control conditions to 
24.9 ± 2.0 pA/pF in the presence of 50 µmol/l 1-EBIO. 
Clotrimazole (1 µmol/l) reduces current density to 9.3 ± 
1.1 pA/pF in the continued presence of 1-EBIO (Figure 
1E; n = 9).  The respective reversal potentials are −41.8 
± 0.7 mV (control), -65.2 ± 3.0 mV (1-EBIO), and -51.7 
± 2.4 mV (1-EBIO and clotrimazole) (Figure 1F), which 
is consistent with the activation and subsequent (partial) 
inhibition of a K+ current. 
Stimulation of migration of PSCs requires KCa3.1 
channels
PSCs are stimulated in a paracrine way by 
neighboring PDAC cells. We mimicked this situation 
in vitro by exposing RLT-PSCs to the supernatant of 
different PDAC cell lines. While the supernatant of 
BxPC3 cells does not increase motility of RLT-PSCs, 
those from Panc-1 and Colo357 cells induce a marked 
activation of RLT-PSC migration. Panel A of Figure 2 
shows the trajectories of individual RLT-PSCs without 
stimulation (top) and after stimulation with the supernatant 
of Panc-1 cells (middle) or Colo357 cells (bottom). The 
length of the trajectories of stimulated cells is much 
longer than under control conditions. This is particularly 
evident when RLT-PSCs are treated with supernatant of 
Colo357 cells. Panel B of Figure 2 depicts the trajectories 
of RLT-PSCs treated with the KCa3.1 channel inhibitor 
TRAM-34 (10 µmol/l). We used this high concentration 
since protein binding of TRAM-34 was found to be 
98% [30]. TRAM-34 efficiently prevents the stimulation 
of migration while it has only a minor effect on basal, 
unstimulated migration. The experiments are summarized 
in panel C. When compared with unstimulated cells, the 
supernatant of Colo357 cells more than doubles the speed 
and translocation (0.45 ± 0.04 µm/min and 48.8 ± 10.2 
µm versus 0.98 ± 0.09 µm/min and 110.7 ± 16.1 µm). 
The stimulation is largely reversed by blocking KCa3.1 
channels with TRAM-34 (69.9 ± 10.1 µm). We also 
observed a stimulatory effect on migration depending 
on KCa3.1 channel activity when RLT-PSCs were treated 
with PDGF (50 ng/ml) which is expressed by PDAC cells 
[6] (see Figure 2D, 2E). It is noteworthy that under all 
conditions KCa3.1 channel blockade caused a decrease of 
the cellular directionality by ~20%.
To rule out that the observed effects of KCa3.1 
channels on migration of RLT-PSCs are a consequence 
of their immortalization we performed additional 
experiments with primary murine PSCs. Having seen an 
effect of KCa3.1 channel blockade on the directionality we 
now studied the effect of TRAM-34 or of KCa3.1 channel 
knock-out on chemotaxis of murine PSCs towards PDGF. 
Murine PSCs migrate more slowly than RLT-PSCs (~8.4 
µm/h versus ~16 µm/h). PDGF, however, also leads to an 
acceleration of murine wtPSCs which then cover ~10.5 
µm/h. Murine wtPSCs chemotax efficiently in a gradient 
of PDGF as indicated by the asymmetric trajectories 
depicted in Figure 3A and 3C. The average chemotactic 
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index is 0.33 ± 0.03 in a gradient of PDGF with peak 
values of up to 0.42 ± 0.03 during the second half of the 
experiment (Figure 3E and 3F). KCa3.1 channel blockade 
with 10 µmol/l TRAM-34 slows down PDGF-stimulated 
murine PSCs to ~8.8 µm/h and causes a marked delay 
in the onset as well as an attenuation of chemotaxis 
(chemotaxis index 0.23 ± 0.03 with peak values of 0.33 ± 
0.04 during the second half of the experiment). The role of 
KCa3.1 channels in murine PSC migration and chemotaxis 
is further confirmed by studying KCa3.1
−/− PSCs (Figure 
3E). Both, the rate of migration (~5.8 µm/h versus ~13.5 
µm/h) and the chemotaxis index (0.15 ± 0.05 versus 0.3 ± 
0.3; Figure 3F) are markedly lower in KCa3.1
−/− PSCs than 
in cells from the respective wildtype littermates. 
Impact of KCa3.1 channels on [Ca2+]i of RLT-
PSCs
We next determined mechanisms by which KCa3.1 
channel blockade impairs migration of PSCs. We first 
tested whether the pretreatment of RLT-PSCs with the 
supernatant of Colo357 cells induced an increase of the 
[Ca2+]i. As shown in Figure 4A the basal [Ca
2+]i is higher in 
pretreated cells. The [Ca2+]i of unstimulated cells amounts 
to 90.2 ± 6.1 nmol/l. It rises to 148.3 ± 21.4 nmol/l when 
cells are exposed for three hours to the Colo357 cell 
supernatant. Application of the KCa3.1 channel blocker 
TRAM-34 (10 µmol/l) induces a decrease of [Ca2+]i to 
95.6 ± 10.2 nmol/l. The corresponding values for RLT-
PSCs stimulated with the supernatant of Panc-1 cells are 
109.1 ± 9.8 nmol/l and 87.0 ± 8.2 nmol/l, respectively. In 
unstimulated cells TRAM-34 does not induce a change of 
[Ca2+]i which remains stable at 87.7 ± 6.0 nmol/l. 
In another set of experiments we also studied the 
effect of depolarizing the cell membrane potential with 
a Ringer's solution containing 50 mmol/l KCl. In RLT-
PSCs stimulated with Colo357 supernatant [Ca2+]i falls to 
a similar extent (-34.1 ± 6.7 nmol/l) as with 500 nmol/l 
TRAM-34 (-27.8 ± 5.5 nmol/l; Figure 4B). Collectively, 
these experiments suggest that KCa3.1 channels regulate 
Figure 1: Expression of KCa3.1 in RLT-PSCs. (A, B) Immunofluorescence and Western blot. Staining of KCa3.1 channels in RLT-
PSCs (A) and primary murine PSCs (B) by indirect immunofluorescence reveals the typical punctate pattern. Inset: Western blot analysis 
yields a band of the expected size (~50 kD). (C) KCa3.1 channels are not detected in PSCs from KCa3.1−/− mice. (D) Original recording of a 
patch clamp experiment in the whole-cell configuration. The holding potential was −40 mV. We applied a voltage ramp of 5 s duration from 
−84 mV + 56 mV. The KCa3.1 channel activator 1-EBIO (50 µmol/l) produced a large outward current which was inhibited by clotrimazole 
(1 µmol/l). (E, F) Summary of the patch clamp experiments. The current densities (pA/pF) are plotted in E., and F. depicts the reversal 
potentials (n = 9). * denotes p ≤ 0.05.
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Figure 2: Stimulation of RLT-PSC migration by conditioned PDAC cell medium and PDGF requires KCa3.1 channel 
activity. (A, B) Trajectories of migrating RLT-PSCs normalized to common starting points in the absence and presence of the KCa3.1 
channel blocker TRAM-34 (10 µmol/l). The radii of the grey circles depict the mean translocation of each cell population. (C) Summary 
of the migration experiments shown in A and B. # denotes statistically significant difference from unstimulated cells, and * indicates a 
significant effect of KCa3.1 channel blockade with TRAM-34 (p < 0.05; n = 20 cells from N ≥ 3 experiments). (D, E) PDGF stimulates 
migration of RLT-PSCs in a KCa3.1 channel dependent manner. D. Speed of migration. E. Translocation. * denotes statistically significant 
difference from unstimulated cells.  n ≥ 47 cells from N ≥ 5 experiments.
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Figure 3: Chemotaxis of primary murine stellate cells towards PDGF is attenuated by KCa3.1 channel inhibition. (A–D) 
Trajectories of individual PSCs normalized to common starting points. The grey shaded triangle indicates the chemotactic PDGF gradient 
with an increasing concentration towards the top. The bold grey lines represent the average movement of the entire cell populations. (A, B) 
PSCs from wt mice in the absence and presence of the KCa3.1 channel blocker TRAM-34. (C, D) PSCs from wt mice and their KCa3.1
−/− 
littermates. (E) Net movement into the direction of the chemotactic gradient. KCa3.1 channel blockade and KCa3.1 knock-out lead to a delay 
and an attenuation of the chemotactic movement. (F) Summary of the chemotactic indices of the experiments shown in (A–D) The left bars 
compare the mean chemotactic index of wt PSCs in the absence and presence of the KCa3.1 channel inhibitor TRAM-34. The right columns 
summarize the experiments with KCa3.1
−/− PSCs compared with the respective wt littermates. n = 22–43 cells from N = 3–4 mice.
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[Ca2+]i of RLT-PSCs by keeping the cell membrane 
potential at a hyperpolarized value. These data are 
consistent with an earlier study proposing the absence of 
voltage-gated Ca2+ channels in PSCs [31].
KCa3.1 channel blockade reduces calpain activity 
in RLT-PSCs
KCa3.1 channel blockade induced a migratory 
phenotype suggestive of impaired detachment. Such an 
example is shown in Figure 4C. Here we superimposed all 
37 images of a migration experiment. Four cell processes 
are clearly visible. The cell center is somewhat out of focus 
indicating that the cell body moved back and forth, whereas 
the peripheral processes remained attached to the substratum. 
Accordingly, the number of lamellipodia rises when PDGF-
stimulated RLT-PSCs are treated with the KCa3.1 channel 
blocker TRAM-34 (4.1 ± 1.0 versus 6.5 ± 1.0).
One of the Ca2+-dependent regulators of focal 
adhesion turnover is calpain. We therefore tested whether 
the decrease of the [Ca2+]i following KCa3.1 channel 
blockade is accompanied by decreased calpain activity. The 
results of these experiments are shown in Figure 4D–4F. 
Using the fluorescent calpain substrate, CMAC, t-BOC-
Leu-Met, we found that calpain activity is reduced after 
treatment with the KCa3.1 blocker TRAM-34 by ~30%.
TRPC3 channels provide KCa3.1 channels with 
Ca2+
Data mining of published microarray analyses 
of microdissected patient tissue samples revealed 
that TRPC3 channels are upregulated in the stromal 
compartment of PDAC as compared to that of chronic 
pancreatitis (Figure 5A). In contrast, KCa3.1 channel 
expression is increased in PDAC cells but not in the 
tumor stroma (Figure 5B).  We therefore tested whether 
TRPC3 channels are also expressed in RLT-PSCs. As 
shown by Western blot and immunofluorescence this is 
the case (Figure 5C). They have a similar distribution 
pattern as KCa3.1 channels. We therefore reasoned 
whether TRPC3 channels might cooperate with KCa3.1 
channels in providing them with Ca2+ ions required for 
their activation. Such a coupling between TRPC3 and 
KCa1.1 channels has been found in podocytes [32]. To 
this end, we performed co-immunostaining of TRPC3 and 
KCa3.1 channels in RLT-PSCs. Figure 5C–5E reveal that 
approximately two thirds of TRPC3 and KCa3.1 channels 
are colocalized. 
Next we evaluated their role in regulating the 
[Ca2+]i of RLT-PSCs (see Figure 6A). [Ca
2+]i rises 
transiently to ~550 nmol/l when stimulated with 50 ng/
ml PDGF. After 5 min [Ca2+]i has gradually fallen to ~400 
nmol/l. Blocking KCa3.1 channels with TRAM-34 in the 
continued presence of PDGF then leads to a decrease of 
[Ca2+]i to ~250 nmol/l. In siTRPC3-RLT-PSCs PDGF 
fails to elicit an increase of [Ca2+]i. 
TRPC3 channels in PDGF-stimulated migration 
of RLT-PSCs
We finally investigated whether TRPC3 channels 
are involved in the stimulation of RLT-PSC migration. 
We compared migration of PDGF-stimulated siTRPC3-
RLT-PSCs with that of control RLT-PSCs transfected 
with scrambled siRNA (Figure 6B and 6C). Control 
cells cover much larger distances (127.8 ± 16.2 µm) than 
siTRPC3 cells (57.7 ± 5.6 µm). Blocking KCa3.1 channels 
with TRAM-34 has no additional inhibitory effect, 
which is consistent with the notion that TRPC3 channels 
are functionally cooperating with KCa3.1 channels by 
providing them with Ca2+.
DISCUSSION
This study is one of the first to explore the 
expression and function of ion channels in pancreatic 
stellate cells. The main findings of our study are that 
(i) pancreatic stellate cells functionally express KCa3.1 
channels whose activity (ii) is required for (directed) 
migration by (iii) regulating the [Ca2+]i and thereby (iv) 
calpain activity. Finally, we showed that (v) the role of 
KCa3.1 channels in cell migration depends on cooperation 
with TRPC3 channels which are upregulated in the 
stroma of PDAC tissue samples. Thus, KCa3.1 channels 
are as expected closely linked to the intracellular Ca2+ 
homeostasis of PSCs. 
So far, only few studies addressed the role of the 
[Ca2+]i in PSC function such as proliferation and the 
molecular nature of the channels involved in Ca2+ signaling 
[20, 31]. They showed that (nuclear) Ca2+ signals are an 
important determinant of the proliferation of activated 
PSCs and that the “Ca2+ signature” of activated PSCs 
differs from that of quiescent PSCs [31]. However, several 
studies performed with hepatic stellate cells (HSCs), close 
“relatives” of PSCs, point to a causal relationship between 
intracellular Ca2+ signaling and pro-inflammatory as well 
as profibrotic events. Thus, norepinephrine-induced Ca2+ 
oscillations were linked to enhanced cytokine secretion (e.g. 
CCL5 (RANTES), IL-8) and thereby autocrine activation 
of HSCs [33]. Their activation by angiotensin II relies on 
more prolonged elevations of the [Ca2+]i that in turn also 
involves the CD38-dependent production of the intracellular 
messengers cyclic ADP-ribose (cADPR) and nicotinic 
acid adenine dinucleotide phosphate (NAADP). This is a 
pathophysiologically relevant mechanism since CD38−/− 
mice are protected to some extent from liver fibrosis induced 
by bile duct ligation [34]. Finally, KCa3.1 inhibition was 
shown to exert antifibrotic effects that could be related to an 
inhibition of TGF-β signaling in hepatic stellate cells [24].
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Figure 4: (A, B) Impact of KCa3.1 channels on the [Ca2+]i of RLT-PSCs stimulated with supernatant from Colo357 PDAC cells. (A) TRAM-
34 (10 µmol/l) reduces the [Ca2+]i of RLT-PSCs stimulated with the supernatants from COLO357 or Panc1 cells (n = 30 cells from N = 6 
experiments each), but has no effect on untreated cells (n = 30 cells from N = 4 experiments). B. Depolarizing the cell membrane potential 
with 50 mmol/l KCl has a similar impact on the [Ca2+]i of activated RLT-PSCs as blocking KCa3.1 channels with 500 nmol/l TRAM-34 
-(n = 14 cells from N = 5 experiments; we only plotted the steady state values of the last 30–60 s of each condition). (C–F) Blocking KCa3.1 
channels impairs deadhesion of RLT-PSCs by reducing calpain activity. (C) “Z-stack” of 37 images acquired in 5 min intervals of a RLT-PSC 
treated with PDGF and TRAM-34. The lamellipodial processes (white arrows) are clearly visible indicating that they hardly moved throughout the 
experiment. (D, E) Fluorescence of the calpain substrate CMAC, t-BOC-Leu-Met in RLT-PSCs treated with PDGF (D) or PDGF and TRAM-34 
(E, F) Summary of N = 7 experiments with n ≥ 30 cells.
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Figure  5: “Data mining” of published microarray analysis from microdissected freshly frozen tissue samples from 
PDAC (n = 14), normal pancreatic tissue (n = 11) and chronic pancreatitis specimens (n = 9) [56, 57] for TRPC3 
(A) and KCa3.1 channel (B) expression. TRPC3 expression is higher in tumor stroma (TS) than in chronic pancreatitis stroma (CPS), and 
that of KCa3.1 channels is higher in tumor epithelium (TE) than in normal epithelial cells (NE). The Cel Files obtained from the Affymetrix 
MAS 5.0 software were loaded into dChip 1.3 (http://www.dchip.org), then normalized, and expression values as well as absolute calls were 
calculated using the PM/MM model. The analysis was carried out by using R-software, performing Wilcoxon-Mann-Whitney-Test and 
filtered by p-value (< 0.05) with Bonferroni’s correction method. n.s.: not significant. (C–E) TRPC3 und KCa3.1 channels are colocalised 
in RLT-PSCs. The Western blot verifies the TRPC3 antibody specificity (inset in C). (C) Co-staining of TRPC3 channels (red) and KCa3.1 
channels (green). The inset (lower left) shows the boxed area in high magnification. (D) Intensity profile along the dotted line in the inset of 
(C). The fluorescent spot “1” consists of colocalized TRPC3 and KCa3.1 channels while “2” is a KCa3.1 channel only. (E) Summary of the 
quantitative analysis. Approximately two thirds of the channel proteins are colocalized (n = 30 cells from N = 3 experiments).
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Figure 6: Impact of TRPC3 channels on the [Ca2+]i and migration of RLT-PSCs. (A) PDGF induces a transient rise of the 
[Ca2+]i. Inhibition of KCa3.1 channels with TRAM-34 leads to a reduction of the [Ca
2+]i (n = 19 from N = 3 experiments). Knockdown of 
TRPC3 channels abrogates the increase of the [Ca2+]i following stimulation with PDGF (n = 41 from N = 3 experiments). (B) Trajectories 
of RLT-PSCs transfected with scrambled siRNA or with siTRPC3 RNA. The trajectories are normalized to common starting points, and 
the radii of the grey circles represent the mean translocation of the cell populations. (C) Summary of the migration experiments. siTRPC3 
transfection strongly reduced the translocation and makes the cells unresponsive to the KCa3.1 channel blocker TRAM-34. n ≥ 31 cells from 
N ≥ 3 experiments.
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To our knowledge there are only very few studies 
showing a direct role of TRP channels in PSC function. 
TRPC1 channels are contributing to the pressure-induced 
activation of PSCs as revealed by a TRPC1-dependent 
stimulation of migration and Ca2+ influx [22]. TRPA1 
channels are involved in the development of acute and 
chronic pancreatitis. Since they were rather found in 
pancreatic nerve fibers and dorsal root ganglia neurons 
innervating the pancreas than in PSCs, these channels 
were proposed to mediate a neurogenic inflammation of 
the pancreas [35, 36]. Thus, in this model TRPA1 channels 
were thought to exert an indirect effect on pancreatic 
stellate cells. TRPV4 channels are functional in PSCs 
[19]. However, the fact that TRPV4−/− mice developed 
the same degree of (acute) pancreatitis as wildtype mice 
argues against a role of TRPV4 channels in this disease. 
Our findings could point to a role of TRPC3 channels in 
pancreatitis. The attenuation of an acute pancreatitis in 
TRPC3−/− animals was explained on the basis of an altered 
exocytotic protease secretion from acinar cells. In contrast 
to wt cells, exocytosis was maintained in TRPC3−/− acinar 
cells during supramaximal stimulation thereby preventing 
their pathological intracellular activation of proteases [32]. 
Since PSCs also become activated in an acute pancreatitis 
[37] our findings raise the possibility that a diminished 
activation of PSCs might have also contributed to the 
attenuated acute pancreatitis in TRPC3−/− mice [38]. Along 
these lines it was also suggested that bradykinin-mediated 
Ca2+ signaling in PSCs could contribute to causing an ACE 
blocker-induced acute pancreatitis. These drugs inhibit 
bradykinin breakdown and could thereby activate PSCs 
by augmenting intracellular Ca2+ [39]. Collectively, these 
studies show that Ca2+ signaling plays an important role 
in stellate cell activation and hence qualifies the involved 
Ca2+ (sensitive) transport proteins as potential targets in 
stellate cell-directed antifibrotic and antiinflammatory 
therapies [40, 41]. However, so far there is no direct 
evidence for a role of ion channels in PSCs in the context 
of PDAC.
We found that KCa3.1 and TRPC3 channels 
play important roles in stimulated migration of PSCs. 
Previously, we suggested that ion channels like KCa3.1 
are part of the migratory machinery by inducing 
localized changes of cell volume (reviewed in [27]). This 
hydrodynamic model of cell migration was confirmed 
by other groups [42–44]. Here, we report an additional 
mechanism by which KCa3.1 channels can affect cell 
migration, namely by cooperating with TRPC3 channels. 
We found in PSCs that KCa3.1 and TRPC3 channels 
are closely colocalized in the plasma membrane so 
that Ca2+ entering the cell via TRPC3 channels can 
activate neighboring KCa3.1 channels. The ensuing 
hyperpolarization of the cell membrane potential increases 
or maintains the electrochemical driving force for Ca2+ 
entry. Conversely, a depolarization of the cell membrane 
potential by either blocking KCa3.1 channels or by 
exposing the cell to 50 mmol/l KCl leads to a decrease of 
the [Ca2+]i. An excessive positive feedback between KCa3.1 
activation induced by TRPC3-mediated Ca2+ influx may 
be prevented by the depolarizing impact of cation influx 
through TRPC3 channels. Alternatively, it is conceivable 
that the increase of the [Ca2+]i also activates other ion 
channels that depolarize the cell membrane potential such 
as TRPM4 channels or members of the ANO/TMEM16 
family of Cl- channels [45, 46]. However, because of the 
limited knowledge of the PSC transportome these two 
latter theories await experimental verification. 
Led by the observation that KCa3.1 channel blockade 
results in impaired deadhesion of PSCs we studied the role 
of the Ca2+ sensitive protease calpain which is a regulator 
of focal adhesions [47]. In T lymphocytes inhibition 
or knockdown of calpain induced a similar migratory 
phenotype as in PSCs treated with the KCa3.1 channel 
blocker TRAM-34. The detachment of the trailing edge 
was disturbed [47]. So far we do not know whether the 
impaired directionality and chemotaxis following KCa3.1 
channel inhibition is also due to reduced calpain activity. 
In neutrophils calpain is involved in chemotaxis [48]. 
The cooperation between KCa3.1 and TRPC3 
channels is reminiscent to findings made in rat mesenteric 
artery endothelial cells where a similar functional 
interaction between TRPC3 and KCa3.1 channels was 
found [49]. In migrating glioma cells TRPC1 and ClC-3 
channels form a functional unit colocalized in caveolae. 
The role of ClC-3 channels in migration and chemotaxis 
depends on their supply with Ca2+ ions via TRPC1 
channels [50]. Our results suggest that KCa3.1 channels 
“utilize” Ca2+ ions entering the cell via TRPC3 channels. 
In Figure 7 we present a model of the cooperation between 
KCa3.1 and TRPC3 channels in PSC migration. Our 
findings help to better understand the physiology of PSCs 
which is important when viewed against the background 
of the controversial discussion on the role of PSCs in the 
progression of PDAC [10]. Our findings and those from 
other groups in hepatic stellate cells clearly show that 
ion channels are crucial players in PSC physiology and 
pathophysiology.
MATERIALS AND METHODS
Cell culture
Experiments were performed with a cell line 
of human pancreatic stellate cells, RLT-PSC [51] and 
three PDAC cell lines, BxPC3, Panc1, and Colo357. 
They were cultured in DMEM/F12 (RLT-PSC), RPMI 
1640 (BxPC3), DMEM/RPMI 1640 (Colo357) and 
DMEM (Panc1) supplemented with 10% fetal calf serum 
(FCS, PAA Gold) at 37°C in a humidified air/5% CO2 
atmosphere. PDAC cells were grown for three days 
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to 80% confluence before conditioned medium was 
collected. It was cleared by sterile filtration and stored 
at 4°C before use.
Isolation of primary murine pancreatic stellate 
cells
Procedures were approved by the local authorities. 
The pancreata of 8 - 12 weeks old mice (C57BL/6; Charles 
River, Sulzfeld, Germany) or of KCa3.1
−/− mice and the wt 
littermates (SV129 background) were removed after the 
animals were anaesthetized with isofluran and killed by 
cervical dislocation. The pancreas was isolated, cut into 
pieces and suspended in 3 ml Grey’s balanced salt solution 
(GBSS) containing 2.5 mg collagenase P. After shaking 
for 30 min at 37°C the enzyme-containing solution was 
further diluted with GBSS and centrifuged. The pellet 
was resuspended in DMEM/F-12 medium containing 
10% FCS and 1% penicillin/streptomycin and plated in an 
FCS-coated cell culture dish. After two hours, the dish was 
washed with media. Since PSCs were the only cells that 
attached strongly [20] they could be easily isolated from 
the other non-adherent cells. Primary murine PSCs were 
used for the experiments after passaging them 1 to 2 times. 
The identity of primary murine PSCs was revealed by the 
disappearance of vitamin A droplets and the appearance 
of α-smooth muscle actin and glial fibrillary acidic protein 
after a couple of days in culture.
TRPC3 knockdown
RLT-PSCs were grown over night in a 60 mm 
dish to 70% confluency. TRPC3 siRNA or control 
siRNA (Invitrogen; 24 pmol/l each) were mixed with 
Opti-MEM (Invitrogen) and siRNA Lipofectamin 
(Invitrogen) according to the manufacturer’s instructions. 
We used the following double-stranded oligos: sense: 
5ʹ-GCAGCAGCUCUUGACGAUCUGGUAU-3ʹ antise 
nse: 5ʹ-AUACCAGAUCGUCAAGAGCUGCUGC-3ʹ 
[52]. Cells were used for experiments 48 h after transient 
transfection. In parallel to migration experiments and 
measurements of [Ca2+]i knockdown efficiency was 
confirmed by Western blot.
Western blot
RLT-PSCs grown to 80% confluency were washed 
before lysis in 50 mmol/l Tris-HCl pH 7.6, 150 mmol/l 
NaCl, 10 mmol/l Nonidet-P40, 3.5 mmol/ SDS, 10% 
Na-deoxycholate, PhosSTOP (phosphatase inhibitor 
cocktail; Sigma) and cOmpleteMini (protease inhibitor 
cocktail; Sigma). Lysates were size-fractionated with 
SDS-PAGE (10%) and blotted onto PVDF membranes. 
KCa3.1 and TRPC3 channel proteins were labelled by 
successive incubation with the respective primary (rabbit 
anti-KCa3.1, Sigma-Aldrich, 1.0 mg/ml, 1:2.000; rabbit 
anti-TRPC3, Alomone Laboratories, 0.8 mg/ml, 1:400; 
mouse anti-actin, Sigma-Aldrich, 30.3 mg/ml, 1:15.000) 
and secondary antibodies (peroxidase conjugated goat 
anti-rabbit and anti-mouse, Sigma-Aldrich) followed by 
chemiluminescent detection (Pierce).
Immunofluorescence
Staining of KCa3.1 channels was performed 
according to a protocol described previously [26]. Antibody 
Figure 7: Summary scheme of how KCa3.1 and TRPC3 channels cooperate with each other in order to support 
migration. KCa3.1 channels provide electrochemical driving force for Ca2+ entry via TRPC3 channels. [Ca2+]i in turn maintains activity of 
KCa3.1 channels and, among others, activates calpain thereby promoting deadhesion of migrating stellate cells.
Oncotarget780www.impactjournals.com/oncotarget
titers were: primary rabbit anti-KCa3.1 (1.0 mg/ml), 
1 : 1.000, 1h and secondary goat anti-rabbit Alexa 488, 1 : 
1.000, 1h. After staining the cells were fixed again for 10 
min in 3.5% paraformaldehyde.
For double-labelling of KCa3.1 and TRPC3 channels 
this protocol was modified because both primary 
antibodies were derived from rabbit. First, KCa3.1 channels 
were stained as described above. Then the cells were fixed 
for 10 min in 3.5% paraformaldehyde before staining of 
TRPC3 channels (TRPC3 antibody concentration 0.8 mg/
ml, 1:300) following the same protocol. We maximally 
increased the concentration of secondary antibody used 
to label KCa3.1 channels (goat anti-rabbit Alexa 488, 1 : 
200) without obtaining unspecific binding in the absence 
of the primary antibody. At the same time we maximally 
diluted the concentration of the secondary antibody used 
to mark TRPC3 channels (goat anti-rabbit Cy3, 1 : 800) 
without diminishing the TRPC3 staining density. The high 
concentration of goat anti-rabbit Alexa 488 secondary 
antibody saturated all binding sites of primary anti-KCa3.1 
antibodies because the subsequent incubation with goat 
anti-rabbit Cy3 (1 : 800) did not produce any additional 
labelling.
We used an inverted microscope (Axiovert 200, 
Zeiss, Oberkochen, Germany) equipped with a digital 
camera (model 9.0, RT-SE-Spot, Visitron, Puchheim, 
Germany) and a 100x, 1.45 oil immersion objective 
for documentation. Data acquisition and analysis were 
performed with Metavue software (Visitron). The average 
density and colocalization of KCa3.1 and TRPC3 channels 
were determined in 6 areas (3 µm x 3 µm) per cell. After 
correcting pixel shifts of superimposed images, we used 
the linescan tool in order to determine the optical center 
of the fluorescent spots. We assumed a colocalization 
between KCa3.1 and TRPC3 channels when the distance 
between their optical centers was less than 1 pixel 
(corresponding to 60 nm)[53].
Patch clamp experiments
Functional expression of KCa3.1 channels was 
revealed by performing the patch clamp experiments using 
the whole cell configuration as described previously [29]. 
Experiments were performed at room temperature. The 
holding potential was −40 mV which is close to the cell 
membrane potential. Current amplitude was determined 
at the end of the depolarizing ramp protocol (5 s; -84 to 
+56 mV). The extracellular solution was composed of 
(in mmol/l): 140 NaCl, 5 KCl, 10 HEPES, 1 MgCl2, and 
1 CaCl2, pH 7.4 with NaOH. The intracellular solution 
contained (in mmol/l): 140 KCl, 10 HEPES, 1.3 EGTA, 
1.217 CaCl2, and 1 MgCl2, pH 7.4 with KOH. The 
calculated free Ca2+ concentration of the internal solution 
was 1 µmol/l. Clotrimazole (1 µmol/l) and 1-ethyl-2-
benzimidazolone (1-EBIO; 50 µmol/l) were dissolved in 
DMSO, added to the extracellular solution, and applied 
for a time period of 2 and 10 min, respectively. The final 
DMSO concentration was < 0.1%. Recordings were 
analyzed using FitMaster and Origin 7.5 software.
Migration experiments
Migration of PSCs was quantified by means of live-
cell imaging as described previously [28]. Cells were 
seeded 3 h prior to the experiment into tissue culture flasks 
coated with a “basement membrane-like matrix” (Table 1). 
Image acquisition in 5 min intervals was controlled by 
HiPic or WASABI software (Hamamatsu). Migration was 
quantified as the movement of the cell center with time. 
We calculated the cell speed (in µm/min) as a three-point 
difference quotient and the translocation (in µm) as the net 
distance covered within the experiment. The directionality 
was derived from the quotient of translocation and total 
path length. 
Chemotaxis experiments
Chemotaxis experiments were performed in 
chemotaxis chambers (ibidi, Martinsried, Germany) 
coated for one hour with a “basement membrane”-like 
matrix (see Table 1). Cells were seeded in HEPES-
buffered RPMI at a density of 8 × 105 cells/ml and 
allowed to settle for three hours. Thereafter, the medium 
was exchanged and if applicable supplemented with 
10 µmol/l TRAM-34. A chemotactic gradient was 
established according to the manufacturer’s instructions 
by adding 17 µl of PDGF-containing medium (400 ng/ml) 
to one of the reservoirs of the chemotactic chamber. 
Table 1: Composition of the extracellular matrices
basement membrane matrix
RPMI 5× 10.4 g/L
HEPES 5× 10 mmol/L
NaOH ~15 µL 1M NaOH per 1 mL matrix solution [58]
laminin 100 µg/mL
fibronectin 100 µg/mL
collagen IV 1 mg/µL
H2O ad 1 mL
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Chemotaxis was monitored by means of live-cell imaging 
for ~16 h in 8 min intervals. The migratory behavior was 
analysed by manually tracking the cell center of each cell. 
Speed and translocation were calculated as described 
above. Chemotactic efficiency was determined as the 
chemotaxis index (CI) which is the ratio of net movement 
into the direction of the gradient and the total distance 
covered during the course of the experiment. Movement 
towards increasing concentrations of PDGF is indicated 
by a positive CI.
Measurements of the intracellular Ca2+ 
concentration
We determined the intracellular Ca2+ concentration 
([Ca2+]i) ratiometrically with the fluorescent Ca
2+ 
indicator fura-2 as described previously [54]. Cells were 
plated on glass bottom dishes (Willco, Amsterdam, The 
Netherlands) coated with a basement membrane-like 
matrix and pretreated in the same way as for migration 
experiments. 3 h after plating, cells were loaded with 
fura2-AM (3 µmol/l, Calbiochem) for 20 min at 37°C 
in the respective culture medium. Then the cells were 
transferred to the stage of an inverted microscope 
(Axiovert 200, Zeiss) and continuously superfused with 
prewarmed (37°C) Ringer’s solution of the following 
composition (in mmol/l): 122.5 NaCl, 5.4 KCl, 1.2 
CaCl2, 0.8 MgCl2, 10 HEPES, 5.5 glucose, pH7.4. When 
indicated the extracellular K+ concentration was elevated 
to 50 mmol/l – isosmotically replacing 44.6 mmol/l NaCl. 
The mean cellular fluorescence intensities were corrected 
by background subtraction and measured in 10 s intervals. 
Ca2+ measurements were calibrated at the end of each 
experiment. Maximal and minimal ratios were determined 
separately for each cell following the application of 
Ringer’s solutions containing ionomycin (1 μM) and either 
5 mM EGTA or 5 mM Ca2+.
Determination of calpain activity 
To determine calpain activity in single cells the Boc 
assay was used [55]. Glass bottom dishes (Greiner Bio-
One, Frickenhausen, Germany) were coated for 30 min 
with 1:10 diluted basal membrane-like matrix, before ~2.3 
× 104 cells were plated in growth medium to attach for 
3–4 hours at 37°C and 5% CO2, 95% air. 5 min prior to 
the experiment DMEM/F12 medium was replaced with 
Hepes-buffered Ringer solution. Cells were then either 
treated in the presence or absence of 50 ng/ml PDGF 
with DMSO (1:1000) or TRAM-34 (10 µmol/l) for 30 
min. Thereafter, cells were transferred to the microscope 
stage (Axiovert 200) and the calpain substrate 7-amino-
4-chloromethylcoumarin, t-BOC-L-leucyl-L-methionine 
amide (CMAC, t-BOC-Leu-Met; 10 µM; Molecular 
Probes) was added. After 20 min at 37°C fluorescence 
images were taken using a digital camera (model 9.0, RT-
SE-Spot, Visitron) and the MetaVue software (Visitron). 
We used the following filter set: excitation 365/12 nm, 
beam splitter 395 nm, emission 397 nm. Image exposure 
settings were identical within each experiment: 100 msec 
for CMAC, t-BOC-Leu-Met. Fluorescence intensity was 
measured over the entire projected cell area and corrected 
for background fluorescence in ImageJ.
Statistics
All data are presented as means ± SEM. Statistically 
significant differences were determined with paired or 
unpaired t-test or with one-way ANOVA and post hoc 
Bonferroni test for multiple comparisons as appropriate. 
For non-parametric comparison of two groups, we applied 
Wilcoxon-Mann-Whitney-Test.
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